• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CD3/TCR复合物相关淋巴细胞激活基因-3分子抑制CD3/TCR信号传导。

CD3/TCR complex-associated lymphocyte activation gene-3 molecules inhibit CD3/TCR signaling.

作者信息

Hannier S, Tournier M, Bismuth G, Triebel F

机构信息

Laboratoire d'Immunologie Cellulaire, Institut Gustave-Roussy, Villejuif, France.

出版信息

J Immunol. 1998 Oct 15;161(8):4058-65.

PMID:9780176
Abstract

The lymphocyte activation gene-3 (LAG-3) molecule is a T cell activation Ag closely related to CD4 at the gene and protein levels. We investigated whether LAG-3 itself may down-regulate the immune response by interfering with TCR signaling. The binding of Ab to the LAG-3 molecule followed by cross-linking (XL) inhibits cell proliferation and cytokine secretion in response to CD3XL on activated T cells. LAG-3XL-induced down-regulation is associated with functional unresponsiveness, as well as with high CD25 expression levels and reversion by exogenous IL-2. It is also associated with a down-modulation of CD3/TCR complex expression. At the biochemical level, LAG-3XL inhibits calcium response to CD3 stimulation. This inhibition is observed with different LAG-3- and CD3-specific mAbs on condition that the two receptors are cross-linked together. Finally, the capping of CD3 was shown to induce cocapping of LAG-3 molecules. Together, these results show that CD3/TCR complex-associated LAG-3 molecules can play an active role in negatively regulating the CD3/TCR activation pathway. They ultimately suggest that LAG-3 is an inhibitory receptor in activated T lymphocytes.

摘要

淋巴细胞激活基因-3(LAG-3)分子是一种在基因和蛋白质水平上与CD4密切相关的T细胞激活抗原。我们研究了LAG-3本身是否可能通过干扰TCR信号传导来下调免疫反应。抗体与LAG-3分子结合后进行交联(XL)可抑制活化T细胞对CD3XL的细胞增殖和细胞因子分泌。LAG-3XL诱导的下调与功能无反应性有关,也与高CD25表达水平和外源性IL-2的逆转有关。它还与CD3/TCR复合物表达的下调有关。在生化水平上,LAG-3XL抑制对CD3刺激的钙反应。在两个受体交联在一起的条件下,用不同的LAG-3和CD3特异性单克隆抗体可观察到这种抑制作用。最后,CD3的封帽显示可诱导LAG-3分子的共封帽。总之,这些结果表明,与CD3/TCR复合物相关的LAG-3分子可在负向调节CD3/TCR激活途径中发挥积极作用。它们最终表明LAG-3是活化T淋巴细胞中的一种抑制性受体。

相似文献

1
CD3/TCR complex-associated lymphocyte activation gene-3 molecules inhibit CD3/TCR signaling.CD3/TCR复合物相关淋巴细胞激活基因-3分子抑制CD3/TCR信号传导。
J Immunol. 1998 Oct 15;161(8):4058-65.
2
LAP, a lymphocyte activation gene-3 (LAG-3)-associated protein that binds to a repeated EP motif in the intracellular region of LAG-3, may participate in the down-regulation of the CD3/TCR activation pathway.LAP是一种与淋巴细胞激活基因3(LAG-3)相关的蛋白,它与LAG-3细胞内区域的一个重复EP基序结合,可能参与CD3/TCR激活途径的下调。
Eur J Immunol. 2001 Oct;31(10):2885-91. doi: 10.1002/1521-4141(2001010)31:10<2885::aid-immu2885>3.0.co;2-2.
3
A novel model for antigen-dependent activation of normal human T cells. Transmembrane signaling by crosslinkage of the CD3/T cell receptor-alpha/beta complex with the cluster determinant 2 antigen.一种正常人T细胞抗原依赖性激活的新模型。通过将CD3/T细胞受体α/β复合物与簇分化抗原2交联进行跨膜信号传导。
J Exp Med. 1990 Jun 1;171(6):1965-79. doi: 10.1084/jem.171.6.1965.
4
Genetic analysis of integrin activation in T lymphocytes.T淋巴细胞中整合素激活的遗传分析。
Immunol Rev. 2002 Aug;186:172-88. doi: 10.1034/j.1600-065x.2002.18615.x.
5
The MHC class II ligand lymphocyte activation gene-3 is co-distributed with CD8 and CD3-TCR molecules after their engagement by mAb or peptide-MHC class I complexes.MHC II类配体淋巴细胞激活基因-3在单克隆抗体或肽-MHC I类复合物与CD8和CD3-TCR分子结合后,与它们共同分布。
Int Immunol. 1999 Nov;11(11):1745-52. doi: 10.1093/intimm/11.11.1745.
6
How does T cell receptor clustering impact on signal transduction?T 细胞受体聚集如何影响信号转导?
J Cell Sci. 2019 Feb 11;132(4):jcs226423. doi: 10.1242/jcs.226423.
7
The Multiple Roles of the Cytosolic Adapter Proteins ADAP, SKAP1 and SKAP2 for TCR/CD3 -Mediated Signaling Events.细胞质衔接蛋白 ADAP、SKAP1 和 SKAP2 在 TCR/CD3 介导的信号事件中的多重作用。
Front Immunol. 2021 Jul 6;12:703534. doi: 10.3389/fimmu.2021.703534. eCollection 2021.
8
CD45 modulates T cell receptor/CD3-induced activation of human thymocytes via regulation of tyrosine phosphorylation.CD45通过调节酪氨酸磷酸化来调控T细胞受体/CD3诱导的人胸腺细胞活化。
Eur J Immunol. 1992 Feb;22(2):551-7. doi: 10.1002/eji.1830220238.
9
B and T lymphocyte attenuator interacts with CD3zeta and inhibits tyrosine phosphorylation of TCRzeta complex during T-cell activation.B和T淋巴细胞衰减子与CD3ζ相互作用,并在T细胞活化过程中抑制TCRζ复合体的酪氨酸磷酸化。
Immunol Cell Biol. 2007 Nov-Dec;85(8):590-5. doi: 10.1038/sj.icb.7100087. Epub 2007 Jul 3.
10
Activation of human thymocytes by antibodies to the CD3/T-cell receptor complex: triggering of different epitopes results in different signals.通过针对CD3/T细胞受体复合物的抗体激活人胸腺细胞:触发不同表位会产生不同信号。
Cell Immunol. 1991 Sep;136(2):318-28. doi: 10.1016/0008-8749(91)90355-f.

引用本文的文献

1
Sabotaging TCR signaling-LAG3 interferes with the CD3ε-LCK interaction.破坏TCR信号传导——LAG3干扰CD3ε与LCK的相互作用。
Cell Res. 2025 Aug 22. doi: 10.1038/s41422-025-01168-7.
2
Negative Immune Checkpoint Inhibitors.阴性免疫检查点抑制剂
Pharmaceutics. 2025 May 28;17(6):713. doi: 10.3390/pharmaceutics17060713.
3
Pan-cancer analysis of co-inhibitory molecules revealing their potential prognostic and clinical values in immunotherapy.共抑制分子的泛癌分析揭示了它们在免疫治疗中的潜在预后和临床价值。
Front Immunol. 2025 Mar 24;16:1544104. doi: 10.3389/fimmu.2025.1544104. eCollection 2025.
4
Immune checkpoint blockade for cancer therapy: current progress and perspectives.用于癌症治疗的免疫检查点阻断:当前进展与展望。
J Zhejiang Univ Sci B. 2025 Mar 13;26(3):203-226. doi: 10.1631/jzus.B2300492.
5
LAG Time in the Era of Immunotherapy-New Molecular Insights Into the Immunosuppression Mechanism of Lymphocyte Activation Gene-3.免疫治疗时代的延迟时间——淋巴细胞激活基因-3免疫抑制机制的新分子见解
Immunol Rev. 2025 Mar;330(1):e70002. doi: 10.1111/imr.70002.
6
Association Between Common Variants in the / Genes and Risk for Essential Tremor./基因中的常见变异与特发性震颤风险之间的关联。
Int J Mol Sci. 2024 Dec 13;25(24):13403. doi: 10.3390/ijms252413403.
7
LAG3 immune inhibitors: a novel strategy for melanoma treatment.LAG3免疫抑制剂:一种治疗黑色素瘤的新策略。
Front Oncol. 2024 Dec 18;14:1514578. doi: 10.3389/fonc.2024.1514578. eCollection 2024.
8
Lymphocyte-activation gene 3 in cancer immunotherapy: function, prognostic biomarker and therapeutic potentials.癌症免疫治疗中的淋巴细胞激活基因3:功能、预后生物标志物及治疗潜力
Front Immunol. 2024 Nov 26;15:1501613. doi: 10.3389/fimmu.2024.1501613. eCollection 2024.
9
High-resolution profile of neoantigen-specific TCR activation links moderate stimulation to increased resilience of engineered TCR-T cells.新抗原特异性TCR激活的高分辨率图谱将适度刺激与工程化TCR-T细胞的增强恢复力联系起来。
Nat Commun. 2024 Dec 3;15(1):10520. doi: 10.1038/s41467-024-53911-0.
10
Deciphering LAG-3: unveiling molecular mechanisms and clinical advancements.解读淋巴细胞激活基因-3:揭示分子机制与临床进展
Biomark Res. 2024 Oct 18;12(1):126. doi: 10.1186/s40364-024-00671-0.